US 11629195
Anti-IL2 receptor gamma antigen-binding proteins
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 11629195 (Anti-IL2 receptor gamma antigen-binding proteins) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K9/0019, A61P